Psoriasis and Beyond: The global psoriatic disease study

Name: IFPA
Price range: $

Psoriasis is a common chronic inflammatory disease that affects at least 60 million people worldwide¹. People are most familiar with the patches of inflamed skin that are associated with the disease, but the impact of living with psoriasis goes far beyond the skin.

Psoriasis itself, its joint symptoms, and other illnesses that can be associated with it (comorbidities) are collectively referred to as psoriatic disease².

The Psoriasis and Beyond study assessed people’s understanding of psoriatic disease and takes a closer look at its broader impact, including connected comorbidities, how the disease affects a person’s quality of life, and their conversations with their doctor.

Dive into the study findings to discover the many layers of psoriatic disease and start the conversation with your doctor today.

Resources & Tools

Article World Psoriasis Day, Comorbidities, Latest Research

Psoriasis & Beyond

News Living with Psoriatic Disease, IFPA Conference

Psoriasis and Beyond - Interim results

Psoriasis and Beyond: The global psoriatic disease study

Key findings

The vast majority of people living with psoriatic disease are not aware of its systemic nature and associated comorbidities.

Over 80% of participants are unaware of the increased risk of cardiovascular disease and diabetes associated with psoriatic disease³.

The effect of psoriatic disease on a person’s quality of life, their relationships and mental health can be profound.

Even participants with mild disease (60%) reported a moderate to extremely large effect on their quality of life³.

Overall, 59% of participants feel they have no opportunity to talk with their doctor about what they hoped to achieve from their treatment.

Some participants living with psoriatic disease feel their skin and joint symptoms, as well as their quality of life, are not improving adequately on their current treatment³.

Collaboration

Summary of Research Findings

Click below to download the Summary of Research Findings to learn more about the Psoriasis and Beyond study results presented at the 2021 Fall Clinical Dermatology Conference.

Collaboration

About Psoriasis and Beyond

Collaboration

Click below to explore the global and country specific Psoriasis and Beyond publications and learn more about the data.

Psoriasis and beyond global publications

Psoriasis and Beyond country-specific publications

Resources & Tools

Psoriasis and Beyond: The global psoriatic disease study

Key findings

The vast majority of people living with psoriatic disease are not aware of its systemic nature and associated comorbidities.

Over 80% of participants are unaware of the increased risk of cardiovascular disease and diabetes associated with psoriatic disease3.

The effect of psoriatic disease on a person’s quality of life, their relationships and mental health can be profound.

Even participants with mild disease (60%) reported a moderate to extremely large effect on their quality of life3.

Overall, 59% of participants feel they have no opportunity to talk with their doctor about what they hoped to achieve from their treatment.

Some participants living with psoriatic disease feel their skin and joint symptoms, as well as their quality of life, are not improving adequately on their current treatment3.

Collaboration

Summary of Research Findings

Click below to download the Summary of Research Findings to learn more about the Psoriasis and Beyond study results presented at the 2021 Fall Clinical Dermatology Conference.

Collaboration

About Psoriasis and Beyond

Collaboration

Click below to explore the global and country specific Psoriasis and Beyond publications and learn more about the data.

Psoriasis and beyond global publications

Psoriasis and Beyond country-specific publications

Resources & Tools

Over 80% of participants are unaware of the increased risk of cardiovascular disease and diabetes associated with psoriatic disease³.

Even participants with mild disease (60%) reported a moderate to extremely large effect on their quality of life³.

Some participants living with psoriatic disease feel their skin and joint symptoms, as well as their quality of life, are not improving adequately on their current treatment³.